14-94378613-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_ModerateBP6_Very_Strong
The NM_000295.5(SERPINA1):c.1093G>A(p.Asp365Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000923 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000295.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINA1 | NM_000295.5 | c.1093G>A | p.Asp365Asn | missense_variant | 5/5 | ENST00000393087.9 | NP_000286.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINA1 | ENST00000393087.9 | c.1093G>A | p.Asp365Asn | missense_variant | 5/5 | 1 | NM_000295.5 | ENSP00000376802.4 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251350Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135850
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461882Hom.: 0 Cov.: 33 AF XY: 0.0000468 AC XY: 34AN XY: 727238
GnomAD4 genome AF: 0.000480 AC: 73AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000417 AC XY: 31AN XY: 74414
ClinVar
Submissions by phenotype
Alpha-1-antitrypsin deficiency Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | - - |
Likely benign, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
SERPINA1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The SERPINA1 c.1093G>A variant is predicted to result in the amino acid substitution p.Asp365Asn. This variant is also known as p.Asp341Asn and P Saint Albans and has been associated with normal levels of alpha-1 antitrypsin in serum (Holmes et al. 1990. PubMed ID: 2240842). This variant was suggested to be in cis (i.e. on the same chromosome) with a pathogenic allele known as the Z allele (p.Glu366Lys) in a patient, but it was not considered to be a cause of disease in the patient (Graham et al. 2015. PubMed ID: 26321041). This variant has been characterized as a variant of uncertain significance in one study (Dorschner et al. 2013. PubMed ID: 24055113), but more recent studies considered this variant as a normal allele (Amendola et al. 2015. PubMed ID: 25637381; Wiesemann et al. 2022. PubMed ID: 36367950). This variant is reported in 0.14% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 07, 2015 | - - |
PI P(ST. ALBANS) Other:1
other, no assertion criteria provided | literature only | OMIM | Jul 15, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at